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Adaptive dynamics of hematopoietic stem cells and their supporting
stroma: A model and mathematical analysis
Thanh Nam Nguyen ∗† Jean Clairambault ∗ Thierry Jaffredo ‡ Benôıt Perthame ∗
Delphine Salort †
Abstract
We propose a mathematical model to describe the evolution of hematopoietic stem cells (HSCs) and stromal
cells in considering the bi-directional interaction between them. Cancerous cells are also taken into account
in our model. HSCs are structured by a continuous phenotype characterising the population heterogeneity in
a way relevant to the question at stake while stromal cells are structured by another continuous phenotype
representing their capacity of support to HSCs.
We then analyse the model in the framework of adaptive dynamics. More precisely, we study single Dirac
mass steady states, their linear stability and we investigate the role of parameters in the model on the nature
of the evolutionary stationary distributions (ESDs) such as monomorphism, dimorphism and the uniqueness
properties. We also study the dominant phenotypes by an asymptotic approach and we obtain the equation for
dominant phenotypes. Numerical simulations are employed to illustrate our analytical results. In particular,
we represent the case of the invasion of malignant cells as well as the case of co-existence of cancerous cells
and healthy HSCs.
MSC (2010). 35B40, 35Q92, 45J05, 45M10, 92C37, 92D15, 92D25.
Keywords. Adaptive cell population dynamics, hematopoietic stem cells, stromal cells, leukemic stem cells,
Dirac concentrations, asymptotic methods.
1 Introduction
Hematopoietic stem cells (HSCs), developing in the bone marrow, are immature cells that are (the earliest in
development) precursors of all lineages of blood cells: red blood cells, white blood cells and megacaryocytes
(whose fragmentation gives rise to platelets). Blood cell formation, also called hematopoiesis, is a complex
phenomenon basing on the self-renewal, differentiation and maturation of HSCs. It produces about 1011 blood
cells per day in humans and is one of the most stable biological processes in vertebrate organisms. A dysfunction
in the hematopoietic process may induce blood cancer diseases (usually named malignant hemopathies) such as
leukaemia where blockade of maturation and of differentiation occurs in the hematopoietic tree. As a consequence,
malignant cells, resulting from an accumulation of irregular genetic events, appear and proliferate abnormally.
Many mathematical models have been proposed to understand blood cell development and blood diseases.
Mackey [18], inspired by Burns and Tannock [6] and Lajtha [15], have introduced a first mathematical model of
the form of a system of delay differential equations for the dynamics of HSCs where the populations are divided
into two groups (proliferating cells and quiescent cells) and the time delay corresponds to the proliferating phase
duration. Further improvements both in modelling and mathematical analysis are investigated by many authors;
see, for example, [2, 3, 19, 27] — models in the form of ODEs or age-structured transport equations with
applications to chronic myelogenous leukaemia, [12] — a diffusion model including spatial competition between
cells –, reviews [1, 8, 26] and the references therein.
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développement, F-75005 Paris, France
1
Despite extensive studies on the dynamics of HSCs and diseases of the hematopoietic system, none of the
above-mentioned models takes into account the interactions between HSCs and the hematopoietic niche which
is a specific microenvironment ensuring the maintenance and regulation of HCSs locally. It is worth noting that
the interactions between HSCs and their niche, of which mesenchymal stem cells (MSCs) are the most important
component, play a crucial role in the formation of mature blood cells. Also, alterations in the bidirectional
exchanges between HSCs and MSCs may give rise among HSCs to blood cancer stem cells, i.e., leukemic stem
cells, LSCs.
Note that healthy HSCs need the close presence of stromal cells for their development but stromal cells can
proliferate without HSCs. Similar to HSCs, cancer cells in the early stages need stromal cells for their development
whereas in the later stages they can proliferate without support cells. In other words, the more malignant a cell
is, the more independent of stromal cells it is. Here, cancer cells in earlier stages are cells with few mutation
events and cancer cells in later stages stand for the ones with more mutation events. We refer to, for example,
[4, 7, 28] for reviews of the interaction between HSCs and stromal cells, [13] for acute myeloid leukemic cells.
In the present paper, we introduce a mathematical model for the interaction between HSCs and stromal
cells with the aim to better understand the nature of the dialogue between them as well as their dynamics.
We also perform a mathematical analysis for the long-time behaviour of the hepatopoietic and stromal cells in
the framework of adaptive dynamics. Our mathematical model and some notions in the framework of adaptive
dynamics, in particular, evolutionary stable distributions (ESDs) are given in the remaining part of this section.
1.1 A mathematical model
Let nh(t, x) be the population density of hematopoietic stem cells (HSCs) and cancer cells at time t with phenotype
x, continuous structure variable assumed to characterise the population heterogeneity in a way relevant to the
question at stake. Here x will represent a malignancy potential of HSCs, from its minimal (representing a
totally healthy state) to its maximal value (representing maximum malignancy), considered independently of
their stromal support. From a biological point of view, x might represent a pathological combination of both
high plasticity (i.e., ability to change phenotype; stem cells are plastic, but physiologically, they not proliferate
much) and fecundity (i.e., ability to proliferate; differentiated cells are able to proliferate, but physiologically,
they show little plasticity). Let ns(t, y) be their corresponding stromal cell population density - that we will
sometimes call support cells - at time t and with phenotype y (here the continuous phenotype variable y will
denote the supporting capacity of MSCs to HSCs). Assume for simplicity that x and y are real variables with
x ∈ (a, b), y ∈ (c, d), where 0 < a < b and 0 < c < d. Totally healthy HSCs will thus have a phenotype x close to
a, while aggressive leukemic HSCs (i.e., LSCs) will have a phenotype x close to b. We consider a mathematical
model of the form
∂tnh(t, x) =
[
rh(x)− ρh(t)− ρs(t) + α(x)Σs(t)
]
nh, x ∈ (a, b), t > 0,
∂tns(t, y) =
[
rs(y)− ρh(t)− ρs(t) + β(y)Σh(t)
]
ns, y ∈ (c, d), t > 0.
(1.1)
This system is completed with initial data
nh(0, x) = nh0(x) ≥ 0, ns(0, y) = ns0(y) ≥ 0. (1.2)
Here our assumptions and notations are
• ρh(t) :=
∫ b
a
nh(t, x) dx, ρs(t) :=
∫ d
c
ns(t, y) dy are the total populations of HSCs and their support cells,
respectively.
• The terms Σh(t) :=
∫ b
a
ψh(x)nh(t, x) dx,Σs(t) :=
∫ d
c
ψs(y)ns(t, y) dy denote an assumed chemical signal
(Σh) from the hematopoietic immature stem cells (HSCs) to their supporting stroma (MSCs), i.e., “call for
support” and conversely, a trophic message (Σs) from MSCs to HSCs. The cytokine stem cell factor (SCF)
and the C-X-C motif chemokine ligand 12 (CXCL12) are typical examples for such supporting messages
[7, 28]. The nonnegative functions ψh, ψs defined on (a, b) and (c, d) measure the contribution of each
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phenotype in the interactive messages. Assume that ψ′s ≥ 0 (the higher the support phenotype in MSCs,
the stronger the trophic message to HSCs); in the same way, unless otherwise specified, we shall assume
that ψ′h ≥ 0.
• The term rh ≥ 0 represents the intrinsic (i.e., without contribution from trophic messages from MSCs, nor
limitation by the non local logistic terms ρh and ρs, that represent competition for space and nutrients
within the whole population of cells) proliferation rate of HSCs. Assume that rh is non-decreasing (the
more malignant, the more proliferative), rh(a) = 0 and rh(b) > 0.
• The term α ≥ 0, satisfying α′ ≤ 0 and α(b) = 0, is the sensitivity of HSCs to the trophic messages from
support cells
• For the term rs ≥ 0, we assume that r′s(y) ≤ 0 (there is a cost in proliferation for support cells to increase
their support capacity). The term β(y) ≥ 0 with β′(y) ≥ 0 represents the sensitivity of the stromal cells
MSCs to the (call for support) message coming from HSCs.
System (1.1) falls within the broader class of models for interacting populations where competitive, prey-
predator and cooperative types are typical examples of such interaction; see, for example, [22, Chapter 3]. Apart
from the cases mentioned in [22, Chapter 3], in the context of adaptive dynamics, the populations are often
structured by phenotypical traits to take into account the heterogeneity in the population (e.g. [14]). We refer
to [24] a related competitive system with healthy and cancer cells structured by a phenotypic variable related
with their resistance to chemotherapy, to [25] an integro-differential Lotka-Volterra system for the interaction
of N populations (N ≥ 2). In our model, besides the competition terms between cells, we introduce new
terms Σh,Σs, α, β to represent the interacting messages between HSCs and stromal cells. The presence of these
terms makes the problem difficult to study since the nature of (1.1) is unknown and may vary in time. It
could be competitive, co-operative or other types depending on the sign of the terms −ρs(t) + α(x)Σs(t) and
−ρh(t) + β(y)Σh(t). Note that if Σh = Σs = 0, our model reduces to the cases studied in [14, 24]. Also when
ψh = ψs = 1, our problem becomes a particular case of [25].
Let us briefly sum up the meaning of our assumptions. From a biological point of view, the healthy HSCs
cannot proliferate without support cells while cancer cells persist even without support cells. In our model
nh(t, a) corresponds to healthy HSCs and nh(t, b) are leukemic cells since the intrinsic proliferation rate rh
satisfies rh(a) = 0, rh(b) > 0. The monotonicity of rh implies that the higher x is, the more aggressive is a
HSC (in fact, a LSC, since it is then cancerous). Also the monotonicity of α (this function stands for the
sensitivity of HSCs to the trophic messages coming from MSCs) indicates that the more aggressive x is, the less
sensitivity has a HSC to the trophic message sent by MSCs (i.e., the more independent it is from the surrounding
stroma). Moreover, the condition α(b) = 0 shows that n(t, b) (i.e., cancer cells in the latter stages) proliferate
independently of the supporting stroma. Furthermore, the monotonicity of rs, β shows that the more supporting
stromal capacity MSCs have, the less they proliferate and the more sensitive to messages from HSCs they are.
As a simple case, the parameters rh, α, rh, rh, ψh, ψs can be chosen as linear or quadratic functions. For
example, rh, α are given by rh = r
∗
h(x− a) or rh = r∗h(x− a)2, α(x) = α∗(b− x) with positive constants r∗h, α∗,
ψh(x) = x, ψs(y) = y.
A more general model which includes the possibility of mutations has the form:
∂tnh(t, x) = µh(nh)xx +
[
rh(x)− c11(x)ρh(t)− c12(x)ρs(t) + α(x)Σs(t)
]
nh,
∂tns(t, y) = µs(ns)yy +
[
rs(y)− c21(y)ρh(t)− c22(y)ρs(t) + β(y)Σh(t)
]
ns.
(1.3)
Here the diffusion terms represent mutation with rates µh, µs and c11, c12, c22, c22 measure the strength of com-
petition between cells. Problem (1.3) reduces to (1.1) by setting µh = µs = 0 and c11(x) = c12(x) = 1, c21(y) =
c22(y) = 1. Thus (1.1) can be considered as a good approximation of (1.3) in the regime µh, µs << 1 which is
realistic since mutations occur rarely in physiology (to fix ideas, let us say between once every 106 and 109 cell
divisions; of course, in evolved cancers, such low rates may increase).
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Figure 1: An illustration for interacting messages between (healthy and malignant) HSCs and stromal cells.
Interacting messages (Σh,Σs) are represented by black arrow lines. The sensitivities of cells are described by
red curves: HSCs are very sensitive to interacting messages (α > 0) while cancer cells (at their later stages)
are independent of the surrounding stroma (α = 0). Blue curves refer to the intrinsic proliferation rates: HSCs
cannot survive without supporting messages (rh = 0) while cancer cells can proliferate without supporting
messages (rh > 0).
1.2 Some notions in the theory of adaptive dynamics
Hereafter, we will use the notation
∫
to denote the integrals over [a, b] and [c, d], as long as there is no risk of
confusion. Let n̂h, n̂s be measures defined on [a, b], [c, d], respectively. We set
supp n̂h = I ⊂ [a, b], supp n̂s = J ⊂ [c, d],
ρ̂h =
∫
n̂h, ρ̂s =
∫
n̂s, Σ̂h =
∫
ψh(x)n̂h, Σ̂s =
∫
ψs(y)n̂s,
Gh(x) := rh(x)− ρ̂h − ρ̂s + α(x)Σ̂s, Gs(y) := rs(y)− ρ̂h − ρ̂s + β(y)Σ̂h. (1.4)
Definition 1.1. The pair (n̂h, n̂s) is a steady state of (1.1) if
Gh(x) = 0, Gs(y) = 0 for all x ∈ I, y ∈ J. (1.5)
Furthermore, n̂h (resp. n̂s) is said
(i) to be monomorphic if supp n̂h (resp. supp n̂s) is a singleton,
(ii) to be dimorphic if supp n̂h (resp. supp n̂s) is a set of two points.
Definition 1.2. We say that (n̂h, n̂s) is an evolutionary stable distribution (ESD) of problem (1.1) if it is a
steady state and the condition below is fulfilled
Gh(x) ≤ 0 for all x ∈ [a, b] \ I, Gs(y) ≤ 0 for all y ∈ [c, d] \ J. (1.6)
Remark 1.3. It follows from Definition 1.2 that any x ∈ I (resp. y ∈ J) is a maximum point of Gh (resp. Gs).
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As our equation arises from biological cell population dynamics, we only consider non-negative steady states
and ESDs in this paper.
In the context of adaptive dynamics, when (1.5) holds, we say that the phenotypes x ∈ I, y ∈ J are living
in the stationary environment given by (ρ̂h, ρ̂s, Σ̂h, Σ̂s). The functions Gh, Gs are fitness functions associated
with this environment. The quantities Gh(x), Gs(y) are growth rates of phenotypes x, y and they tell us whether
(x, y) can invade this environment: If Gh(x) > 0, Gs(y) > 0, (x, y) can grow and the system will reach a new
equilibrium. We refer to [9, 20] for more details about the framework of adaptive dynamics.
1.3 Summary of main results and organization of the remaining part of the paper
We first present mathematical results to verify biological properties concerning the independence of stromal cells
on HSCs and its vital support to HSCs in Section 2.1. A uniform bound in time and a well-posedness result are
given in Section 2.2.
As generally only a finite number of traits is represented in the equilibrium, we study, for simplicity, in
Section 3, equilibria with only one trait, i.e., those of the form of single Dirac mass. The linear stability result
of single Dirac mass steady states (Theorem 3.2) exhibits the mechanisms by which another trait can or cannot
invade the stationary state produced by a given trait.
ESDs—equilibria corresponding to optimal states of the evolution—are studied in Section 4. We study the
impact of the parameters on the form of ESDs. Two cases are investigated: monomorphic situation (i.e., only
one trait is represented in ESDs) and dimorphic one (two traits are represented in ESDs). More precisely, we
provide sufficient conditions to guarantee that all ESDs are monomorphic or dimorphic (Proposition 4.1). Also
in Theorem 4.2 we obtain a result on the uniqueness of ESDs and we show that this unique ESD is monomorphic.
Another result on the uniqueness of ESD (Theorem 4.5) hold for rather than general functions rh, rs and under
some homogeneity assumptions of stromal cells. This theorem is concerned with more general ESDs which are
not necessary to be monomorphic or dimorphic.
Section 5 is concerned with dominant traits which are the best adapted ones to the environment and favored
at high population densities. These traits are represented by maximum points of the population densities and
change in time because of the variation of environment. We study the movement of these traits in a long time
scale, hence make the change of variable, τ = εt, with small ε > 0. We represent the dynamics of dominant traits
(Theorems 5.1 and 5.2) in the regime as ε→ 0 (asymptotic analysis). Also we obtain the equation for dominant
traits Eq. (5.11).
In Section 6, we provide numerical simulations to illustrate our results and finally, some discussions are given
in Section 7.
2 Preliminary results
2.1 Hematopoietic stem cells or stromal cells without mutual interaction
In the absence of stromal cells, the system (1.1) reduces to the equation
∂tnh(t, x) =
[
rh(x)− ρh(t)
]
nh, x ∈ (a, b), t > 0. (2.1)
Similarly, the behaviour of stromal cells without HSCs is given by
∂tns(t, y) =
[
rs(y)− ρs(t)
]
ns, y ∈ (c, d), t > 0. (2.2)
In view of [23, Theorem 2.1, Page 29], we have the following selection principle:
Lemma 2.1. Suppose that rh is bounded and strictly increasing. Suppose furthermore that rs is bounded and
strictly decreasing. Assume that nh0, ns0 ∈ L1 are positive on [a, b] and [c, d], respectively.
(i) For (2.1), we have nh(t, x)→ rh(b)δ{x=b} weakly in the sense of measures as t→∞.
(ii) For (2.2), we have nh(t, y)→ rs(c)δ{y=c} weakly in the sense of measures as t→∞.
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These results confirm biological properties mentioned in Section 1 about the bi-directional interaction between
HSCs and stromal cells. More precisely, in the absence of stromal cells for HSCs or of HSCs for stromal cells, the
phenotypes of nh and ns, respectively, behave as monomorphic. Moreover, Lemma 2.1 (i) implies that healthy
hematopoietic cells eventually go extinct while cancer cells (with the phenotype y = b) are selected and persist.
Furthermore, stromal cells persist without HSCs and stromal cells with the lowest capacity of support will be
selected (cf. Lemma 2.1 (ii)).
2.2 A well-posedness result
For a function f defined on an interval I, we set
f := min
x∈I
f(x), f := max
x∈I
f(x).
In the results below, we only need the boundedness of rh, rs, α, β, ψh, ψs. We do not need the monotonicity
assumption of these functions.
Proposition 2.2. Assume that rh, rs, α, β, ψh, ψs are non-negative and bounded. Suppose furthermore that
ᾱψ̄s + β̄ψ̄h < 4. (2.3)
Set
ρM := max
(
ρh0 + ρs0,
4 max(r̄h, r̄s)
4− (ᾱψ̄s + β̄ψ̄h)
)
.
Then the solution of (1.1)-(1.2) is non-negative and satisfies
0 ≤ ρh(t) + ρs(t) ≤ ρM for all t ≥ 0. (2.4)
Proof. First note that the solution of (1.1) can be written in the form
nh(t, x) = nh0(x) exp
(∫ t
0
A(σ, x) dσ
)
, ns(t, y) = ns0(y) exp
(∫ t
0
B(σ, y) dσ
)
,
where
A(σ, x) = rh(x)− ρh(σ)− ρs(σ) + α(x)Σs(σ), B(σ, y) = rs(y)− ρh(σ)− ρs(σ) + β(y)Σh(σ).
Thus nh(t, x) ≥ 0, ns(t, y) ≥ 0 since nh0(x) ≥ 0, ns0(y) ≥ 0. This yields the first inequality of (2.4).
Integrating the two equations in (1.1) yields
d
dt
ρh = −ρ2h − ρhρs +
∫
rh(x)nh + Σs(t)
∫
α(x)nh,
d
dt
ρs = −ρ2s − ρhρs +
∫
rs(y)ns + Σh(t)
∫
β(y)ns.
Summing up these two identities and using the non-negativity of nh, ns, we obtain
d
dt
(ρh + ρs) = −(ρh + ρs)2 +
∫
rh(x)nh + Σs(t)
∫
α(x)nh
+
∫
rs(y)ns + Σh(t)
∫
β(y)ns
≤ −(ρh + ρs)2 + max(r̄h, r̄s)(ρh + ρs) + ᾱψ̄sρhρs + β̄ψ̄hρhρs
≤ −(ρh + ρs)2 + max(r̄h, r̄s)(ρh + ρs) +
ᾱψ̄s + β̄ψ̄h
4
(ρh + ρs)
2
=
[
max(r̄h, r̄s)− (1−
ᾱψ̄s + β̄ψ̄h
4
)(ρh + ρs)
]
(ρh + ρs).
Hence the second inequality of (2.4) follows.
Proposition (2.2) and a standard argument imply the following result.
Theorem 2.3. Let (nh0, ns0) ∈ L1(a, b) × L1(c, d) be non-negative. Then (1.1) possesses a unique solution
(nh, ns) ∈ C1([0,∞);L1(a, b)× L1(c, d)).
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3 Steady states and linear stability
Hereafter, for simplicity, we assume that ψh(x) = x, ψs(y) = y. Then Problem (1.1) becomes
∂tnh(t, x) =
[
rh(x)− ρh(t)− ρs(t) + α(x)
∫
yns(t, y)dy
]
nh, x ∈ (a, b), t > 0,
∂tns(t, y) =
[
rs(y)− ρh(t)− ρs(t) + β(y)
∫
xnh(t, x)dx
]
ns, y ∈ (c, d), t > 0.
(3.1)
3.1 Single Dirac mass steady states
Let x̂ ∈ [a, b], ŷ ∈ [c, d]. Consider a particular case where hematopoietic and support cells evolve as single Dirac
masses concentrated at x̂, ŷ. In other words, we focus on the behaviour of the size of the populations. In this
case, nh, ns have the form
nh(t, x) = ρh(t)δ{x=x̂}, ns(t, y) = ρs(t)δ{y=ŷ},
where ρh(t), ρs(t) satisfy 
d
dt
ρh = (rh(x̂)− ρh − (1− α(x̂)ŷ)ρs)ρh,
d
dt
ρs = (rs(ŷ)− (1− β(ŷ)x̂)ρh − ρs)ρs.
(3.2)
We can obtain an explicit form of single Dirac mass steady states.
Lemma 3.1. Let x̂ ∈ [a, b], ŷ ∈ [c, d] and assume that 1− (1− α(x̂)ŷ)(1− β(ŷ)x̂) 6=0. Set
ρ̂h :=
rh(x̂)− rs(ŷ)(1− α(x̂)ŷ)
1− (1− α(x̂)ŷ)(1− β(ŷ)x̂)
, ρ̂s :=
rs(ŷ)− rh(x̂)(1− β(ŷ)x̂)
1− (1− α(x̂)ŷ)(1− β(ŷ)x̂)
. (3.3)
Then (n̂h = ρ̂hδ{x=x̂}, n̂s = ρ̂sδ{y=ŷ}) is a steady state of problem (3.1). If the three conditions below hold 1− (1− α(x̂)ŷ)(1− β(ŷ)x̂) > 0,rh(x̂)− rs(ŷ)(1− α(x̂)ŷ) > 0,
rs(ŷ)− rh(x̂)(1− β(ŷ)x̂) > 0,
(3.4)
then ρ̂h > 0, ρ̂s > 0 and (ρ̂h, ρ̂s) is a linearly stable steady state of (3.2).
Proof. Single Dirac mass steady state solution yields{
rh(x̂)− ρ̂h − ρ̂s + α(x̂)ŷρ̂s = 0,
rs(ŷ)− ρ̂h − ρ̂s + β(ŷ)x̂ρ̂h = 0.
(3.5)
An elementary calculation shows that (ρ̂h, ρ̂s) is a steady state of (3.2) and the corresponding Jacobian matrix
is given by
J =
(
−ρ̂h −(1− α(x̂)ŷ)ρ̂h
−(1− β(ŷ)x̂)ρ̂s −ρ̂s
)
. (3.6)
In view of (3.4), tr(J) < 0,det(J) > 0 so that the two eigenvalues of J are negative. Thus the linear stability of
(ρ̂h, ρ̂s) follows.
3.2 Linear stability of single Dirac mass steady states
The results below are concerned with the linear stability of single Dirac mass steady states among perturbations
of particular forms.
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Theorem 3.2 (Stability of monomorphic steady states). Let (n̂h = ρ̂hδ{x=x̂}, n̂s = ρ̂sδ{y=ŷ}) be a steady state
of (3.1) as in Lemma 3.1. Assume that (3.4) holds. Let x∗, y∗ satisfy x∗ 6= x̂, y∗ 6= ŷ and
Gh(x
∗) < 0, Gs(y
∗) < 0. (3.7)
Then (n̂h, n̂s) is linearly stable among perturbations starting by
nh0 := ε1δ{x=x∗} + (ρ̂h + ε2)δ{x=x̂}, ns0 := ε3δ{y=y∗} + (ρ̂s + ε4)δ{y=ŷ}.
Proof. We linearize the system at (n̂h, n̂s). For gh(t, x) := nh(t, x)− n̂h(x), gs(t, y) := ns(t, y)− n̂s(y) we obtain
∂tgh =
[
rh(x)− ρ̂h − ρ̂s + α(x)
∫
yn̂s
]
gh − n̂h
∫
gh + n̂h
[
−
∫
gs + α(x)
∫
ygs
]
,
∂tgs =
[
−
∫
gh + β(y)
∫
xgh
]
n̂s +
[
rs(y)− ρ̂h − ρ̂s + β(y)
∫
xn̂h
]
gs − n̂s
∫
gs.
Note that gh, gs have the form
gh(t, x) = g
1
h(t)δ{x=x∗} + g
2
h(t)δ{x=x̂}, gs(t, y) = g
1
s(t)δ{y=y∗} + g
2
s(t)δ{y=ŷ}.
Therefore, we obtain 
∂tg
1
h = [rh(x
∗)− ρ̂h − ρ̂s + α(x∗)ŷρ̂s] g1h,
∂tg
1
s = [rs(y
∗)− ρ̂h − ρ̂s + β(y∗)x̂ρ̂h] g1s ,
∂tg
2
h = −ρ̂hg1h + ρ̂h[α(x̂)y∗ − 1]g1s − ρ̂hg2h + ρ̂h(α(x̂)ŷ − 1)g2s ,
∂tg
2
s = ρ̂s(β(ŷ)x
∗ − 1)g1h − ρ̂sg1s + ρ̂s(β(ŷ)x̂− 1)g2h − ρ̂sg2s .
The corresponding matrix is given by
rh(x
∗)− ρ̂h − ρ̂s + α(x∗)ŷρ̂s 0 0 0
0 rs(y
∗)− ρ̂h − ρ̂s + β(y∗)x̂ρ̂h 0 0
−ρ̂h ρ̂h[α(x̂)y∗ − 1] −ρ̂h ρ̂h(α(x̂)ŷ − 1)
ρ̂s(β(ŷ)x
∗ − 1) −ρ̂s ρ̂s(β(ŷ)x̂− 1) −ρ̂s
 .
The eigenvalues of the above matrix are
rh(x
∗)− ρ̂h − ρ̂s + α(x∗)ŷρ̂s, rs(y∗)− ρ̂h − ρ̂s + β(y∗)x̂ρ̂h
and the two eigenvalues of the matrix J in (3.6). All are negative due to (3.7) and Lemma 3.1. Thus the stability
of (n̂h, n̂s) follows.
Interpretations of Theorem 3.2: With the notation (1.4), in view of (3.5), we have Gh(x̂) = 0, Gs(ŷ) = 0.
Also the conditions Gh(x
∗) < 0, Gs(y
∗) < 0 show that the phenotypes x∗, y∗ cannot invade the stable equilibrium
(n̂h, n̂s). As a consequence, no new equilibrium can be reached but a mutant invading the resident population
(x̂, ŷ).
4 Evolutionary stable distributions (ESDs)
4.1 Sufficient conditions for monomophic and dimorphic ESDs
Recall that from the defintion 1.2, an ESD (n̂h, n̂s) is characterised by the conditions (1.5)–(1.6). Graphically, we
plot the curve x ∈ [a, b] 7→ (Z = α(x),W = rh(x)) by the blue curve and the red straight line ZΣ̂s+W = ρ̂h+ ρ̂s;
see Figure 2. Then the conditions (1.5)–(1.6) for n̂h mean that the blue curve must be below the red line and
that the pair (α(x), rh(x)) for all x ∈ I := supp n̂h are the coordinates of the intersection points between the
blue curve and the red line. Similarly, we have the same illustration for n̂s.
If α (resp. rh) is strictly monotone and if rh(α
−1) (resp. α(r−1h )) is concave on [0, α(a)] (resp. [0, rh(b)]). Then
there is at most one intersection point satisfying the conditions (1.5)–(1.6) for n̂h. Thus, the strict monotonicity
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of α implies that I is a singleton, hence n̂h is monomorphic. In the case where rh(α
−1(z)) (resp. α(r−1h )) is
convex, I contains at most two points, thus n̂h is at most dimorphic.
Note that by Remark 1.3, we can also check if an ESD is monomorphic or dimorphic by studying the set of
maximum points of the corresponding fitness functions. We state the above results in the following proposition.
Z
W
rh(b)
α(a)
Z
W
rh(b)
α(a)
Figure 2: Elements for the analysis for n̂h. Left: An example when the blue curve is convex and the dimorphic
situation occurs. Right: An example when the blue curve is concave and the monomorphic situation occurs
Proposition 4.1 (Conditions for monomorphism or dimorphism). Assume that (n̂h, n̂s) is an ESD arbitrarily
that does not vanish. Then n̂h is monomorphic if one of the following hypotheses is fulfilled:
(i) either α is strictly monotone and rh(α
−1) is concave on [0, α(a)],
(ii) or rh is strictly monotone and α(r
−1
h )) is concave on [0, rh(b)],
(iii) or rh, α are strictly concave.
Also n̂h is at most dimorphic if one of the following hypotheses is fulfilled:
(i) either α is strictly monotone and rh(α
−1) is convex on [0, α(a)],
(ii) or rh is strictly monotone and α(r
−1
h )) is convex on [0, rh(b)],
(iii) or rh, α are strictly convex.
Furthermore, the same conclusions as above hold for n̂s provided that similar assumptions on rs, β are supposed.
The next result is concerned with the existence and uniqueness of ESDs. We also show that the unique ESD
is monomorphic and that the concentration points are endpoints of the intervals (a, b), (c, d). For simplicity, set
(a, b) := (1, 2), (c, d) := (3, 4). Here we employ the two distinct sets (1, 2) and (3, 4) to insist on that fact that the
two phenotypes of HSCs and of stromal cells are not the same. We will suppose two of the following assumptions:
(H1) r
′
h(x) + 3α
′(x)r̄s < 0 for all x ∈ (1, 2) and β(y) ≥ 1 for all y ∈ (3, 4),
(H2) r
′
h(x) + 4α
′(x)r̄s > 0 for all x ∈ (1, 2) and β(y) ≤ 1/2 for all y ∈ (3, 4),
(H3) β = β
∗ > 0 is constant and rs is strictly decreasing,
(H4) β is strictly increasing and rs = r
∗
s > 0 is constant.
Theorem 4.2 (Existence and uniqueness of ESDs). Set (a, b) := (1, 2), (c, d) := (3, 4). Suppose that rh, α ∈
C([1, 2]) ∩ C1((1, 2)), rs, β ∈ C([3, 4]) ∩ C1((3, 4)). Suppose furthermore that the pair (n̂h, n̂s) below is non-
negative and that the assumptions (depending on situations) mentioned below hold. Then there exists a unique
(non-negative) ESD and it is monomorphic or vanishes.
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(i) Under the assumptions (H1) and (H3), the unique ESD is given by
n̂h =
rs(3)(3α(1)− 1)
1 + (3α(1)− 1)(1− β∗)
δ{x=1}, n̂s =
rs(3)
1 + (3α(1)− 1)(1− β∗)
δ{y=3}.
(ii) Under the assumptions (H2) and (H3), the unique ESD is given by
n̂h =
rh(2)− rs(3)
2β∗
δ{x=2}, n̂s =
rs(3)− rh(2)(1− 2β∗)
2β∗
δ{y=3}.
(iii) Under the assumptions (H1) and (H4), the unique ESD is given by
n̂h =
r∗s(4α(1)− 1)
1 + (4α(1)− 1)(1− β(4))
δ{x=1}, n̂s =
r∗s
1 + (4α(1)− 1)(1− β(4))
δ{y=4}.
(iv) Under the assumptions (H2) and (H4), the unique ESD is given by
n̂h =
rh(2)− r∗s
2β(4)
δ{x=2}, n̂s =
r∗s − rh(2)(1− 2β(4))
2β(4)
δ{y=4}.
Proof. We only prove (i). The other cases can be proved in the same way. First note that under the assumptions
(H1) and (H3), β = β
∗ ≥ 1. We have Gs(y) = rs(y) − ρ̂h − ρ̂s + β∗Σ̂h is strictly decreasing (by (H3)) so that
it attains its global maximum only at y = 3. This, in view of Remark 1.3, yields that supp n̂s = {3}. As a
consequence, Gs(3) = 0 so that
rs(3)− ρ̂s = ρ̂h − β∗
∫ 2
1
xn̂h ≤ ρ̂h − β∗
∫ 2
1
n̂h = ρ̂h − β∗ρ̂h ≤ 0.
Therefore,
3rs(3) ≤ 3ρ̂s ≤
∫ 4
3
yn̂s = Σ̂s.
This together with the property that α′ ≤ 0 implies that
G′h(x) = r
′
h(x) + α
′(x)Σ̂s ≤ r′h(x) + 3α′(x)rs(3) < 0 for all x ∈ (1, 2),
where we used the hypothesis (H1) in the last inequality. Consequently, Gh is strictly decreasing on [1, 2] so that
it has only one maximum point x = 1. Hence supp n̂h = {1}. The expression of (n̂h, n̂s) follows from (3.3) with
(x̂, ŷ) := (1, 3).
Below, we compute all ESDs explicitly. We also see that the dimorphic situation may occurs. For simplicity,
we only consider the dimorphic distribution for hematopoietic stem cells.
Proposition 4.3 (Explicit formulas of all ESDs). Set (a, b) := (1, 2), (c, d) := (3, 4). Assume that rh is strictly
convex and that α is convex. Suppose furthermore that (H3) is satisfied (i.e., β = β
∗ is a positive constant and
rs is strictly decreasing). Then all ESDs are given by
(i) (n̂h = ρ̂hδ{x=1}, n̂s = ρ̂sδ{y=3}) with
ρ̂h =
rs(3)(3α(1)− 1)
1 + (3α(1)− 1)(1− β∗)
, ρ̂s =
rs(3)
1 + (3α(1)− 1)(1− β∗)
,
provided that ρ̂h ≥ 0, ρ̂s ≥ 0 and
rh(2) ≤
3α(1)rs(3)
1 + (3α(1)− 1)(1− β∗)
. (4.1)
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(ii) (n̂h = ρ̂hδ{x=2}, n̂s = ρ̂sδ{y=3}) with
ρ̂h =
rh(2)− rs(3)
2β∗
, ρ̂s =
rs(3)− rh(2)(1− 2β∗)
2β∗
,
provided that ρ̂h ≥ 0, ρ̂s ≥ 0 and
rh(2) ≥ 3α(1)
rs(3)− rh(2)(1− 2β∗)
2β∗
.
(iii) (n̂h = ρ̂h1δ{x=1} + ρ̂h2δ{x=2}, n̂s = ρ̂sδ{y=3}) with
ρ̂h1 = 2rh(2)
3α(1)− 1
3α(1)
− rh(2)− rs(3)
β∗
,
ρ̂h2 =
rh(2)− rs(3)
β∗
− rh(2)
3α(1)− 1
3α(1)
, ρ̂s =
rh(2)
3α(1)
,
provided that ρ̂h1 ≥ 0, ρ̂h2 ≥ 0, ρ̂s ≥ 0.
Remark 4.4. We can also prove similar results as in Proposition 4.3 when we suppose the hypothesis (H4) instead
of (H3).
Proof. First note that Gh(x) is strictly convex. Thus Gh attains its global maximum only at endpoints of
the interval [1, 2]. Note also that Gs(y) = rs(y) − ρ̂h − ρ̂s + β∗Σ̂h is strictly decreasing so that y = 3 is its
unique maximum point. The above observations and Remark 1.3 imply that supp n̂s = 3 and either supp n̂h =
{1} or supp n̂h = {2} or supp n̂h = {1, 2}.
(i) The case supp n̂h = {1}, supp n̂s = {3}. The expressions of ρ̂h, ρ̂s follows from (3.3) with x̂ = 1, ŷ = 3.
Because of the convexity of Gh and the decreasing monotonicity of Gs, the condition (1.6) is equivalent to
Gh(1) ≥ Gh(2) which implies (4.1). Similarly, Item (ii) — the case supp n̂h = {2}, supp n̂s = {3} — can be
treated in the same way.
(iii) The case supp n̂h = {1, 2}, supp n̂s = {3}. The pair (n̂h, n̂s) have the form
n̂h = ρ̂h1δ{x=1} + ρ̂h2δ{x=2}, n̂s = ρ̂sδ{y=3}.
Thus we have
ρ̂h = ρ̂h1 + ρ̂h2, Σ̂h = ρ̂h1 + 2ρ̂h2, Σ̂s = 3ρ̂s.
The conditions in the definition 1.2 are equivalent to
Gh(1) = Gh(2) = 0, Gs(3) = 0,
that is 
−ρ̂h1 − ρ̂h2 − ρ̂s + 3α(1)ρ̂s = 0,
rh(2)− ρ̂h1 − ρ̂h2 − ρ̂s = 0,
rs(3)− ρh1 − ρh2 − ρ̂s + β∗(ρ̂h1 + 2ρ̂h2) = 0.
Solving this system yields the expressions of ρ̂h1, ρ̂h2, ρ̂s.
Let us consider two concrete examples below.
Example 1: Suppose that rh, α, rs, β are given by
rh(x) = (x− 1)2, α(x) = 2− x, rs(y) =
1
2
+
1
4
(3− y), β = 0.5.
According to Proposition 4.3, there are only two positive ESDs which are
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• Monomorphic distribution:
n̂h(x) =
1
2
δ{x=1}, n̂s(y) =
1
2
δ{y=3},
• Dimorphic distribution:
n̂h(x) =
1
3
δ{x=1} +
1
3
δ{x=2}, n̂s(y) =
1
3
δ{y=3}.
Example 2: Suppose that rh, α, rs, β are given by
rh(x) = 0.75(x− 1)2, α(x) = 0.625(2− x), rs(y) =
1
2
+
1
4
(3− y), β = 0.5.
Then, there is only one positive ESD. This ESD is dimorphic and has the form
n̂h(x) =
1
3
δ{x=1} +
1
6
δ{x=2}, n̂s(y) =
2
5
δ{y=3}.
4.2 Partial uniqueness of ESDs under homogeneity assumptions on stromal cells
We suppose that all stromal cells have some similar properties. More precisely, we consider the case where the
contribution of each phenotype y in the message from stromal cells to HSCs and the sensitivity of stromal cells
to the message from HSCs are the same. Mathematically, assume that the weight function ψs(y) = 1, and that
β > 0 is constant. Suppose furthermore that α(x) = b− x, ψh(x) = x. Problem (1.1) becomes
∂tnh(t, x) =
[
rh(x)− ρh(t)− ρs(t) + (b− x)
∫
ns(t, y)dy
]
nh, x ∈ (a, b), t > 0,
∂tns(t, y) =
[
rs(y)− ρh(t)− ρs(t) + β
∫
xnh(t, x)dx
]
ns y ∈ (c, d), t > 0.
(4.2)
Below we state a result about the partial uniqueness of ESDs.
Theorem 4.5 (Partial uniqueness results of ESDs). Assume that (n̂h, n̂s) and (ñh, ñs) are two (non-negative)
ESDs of the system (4.2). Assume further that β is a positive constant satisfying
(β(1− b) + 1)2 < 4β. (4.3)
Then
ρ̂h = ρ̃h =: H, ρ̂s = ρ̃s =: S, (4.4)∫
rh(x)n̂h − S
∫
xn̂h =
∫
rh(x)ñh − S
∫
xñh, (4.5)∫
rs(y)n̂s − βS
∫
xn̂h =
∫
rs(y)ñs − βS
∫
xñh. (4.6)
Moreover,
(i) If rs is strictly decreasing, then n̂s = ñs either is monomorphic concentrated at y = c or vanishes. Also we
have ∫
rh(x)n̂h =
∫
rh(x)ñh. (4.7)
(ii) In addition to (i), if n̂s does not vanish, then∫
xn̂h =
∫
xñh. (4.8)
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Proof. The definition of ESD and the non-negativity of n̂h yield that
0 ≥
∫ [
rh(x)− ρ̃h − ρ̃s + (b− x)
∫
ñs
]
n̂h
=
∫ {[
rh(x)− ρ̃h − ρ̃s + (b− x)
∫
ñs
]
−
[
rh(x)− ρ̂h − ρ̂s + (b− x)
∫
n̂s
]}
n̂h
= [(ρ̂h − ρ̃h) + (ρ̂s − ρ̃s)] ρ̂h + (ρ̃s − ρ̂s)
∫
(b− x)n̂h. (4.9)
Similarly, it follows from the inequality∫ [
rh(x)− ρ̂h − ρ̂s + (b− x)
∫
n̂s
]
ñh ≤ 0,
that
[(ρ̃h − ρ̂h) + (ρ̃s − ρ̂s)] ρ̃h + (ρ̂s − ρ̃s)
∫
(b− x)ñh ≤ 0. (4.10)
Summing up (4.9) and (4.10), we obtain
(ρ̂h − ρ̃h)2 + (ρ̂s − ρ̃s)(ρ̂h − ρ̃h) + (ρ̃s − ρ̂s)
∫
(b− x)(n̂h − ñh) ≤ 0. (4.11)
Similarly, we deduce from the inequality∫ [
rs(y)− ρ̃h − ρ̃s + β
∫
xñh
]
n̂s +
∫ [
rs(y)− ρ̂h − ρ̂s + β
∫
xn̂h
]
ñs ≤ 0, (4.12)
that
(ρ̂s − ρ̃s)2 + (ρ̂s − ρ̃s)(ρ̂h − ρ̃h) + β
∫
x(ñh − n̂h)(ρ̂s − ρ̃s) ≤ 0.
This together with (4.11) yields
β(ρ̂h − ρ̃h)2 + [β(1− b) + 1](ρ̂h − ρ̃h)(ρ̂s − ρ̃s) + (ρ̂s − ρ̃s)2 ≤ 0.
Equivalently, (√
β(ρ̂h − ρ̃h) +
β(1− b) + 1
2
√
β
(ρ̂s − ρ̃s)
)2
+
(
1− (β(1− b) + 1)
2
4β
)
(ρ̂s − ρ̃s)2 ≤ 0. (4.13)
Therefore, the hypothesis (4.3) yields that the equality in (4.13) (also in all above inequalities) holds. Thus each
term in (4.13) vanishes so that (4.4) follows. The identities (4.5), (4.6) follow from the fact that∫ [
rh(x)− ρ̃h − ρ̃s + (b− x)
∫
ñs
]
n̂h =
∫ [
rh(x)− ρ̂h − ρ̂s + (b− x)
∫
n̂s
]
ñh,∫ [
rs(y)− ρ̃h − ρ̃s + β
∫
xñh
]
n̂s =
∫ [
rs(y)− ρ̂h − ρ̂s + β
∫
xn̂h
]
ñs, (4.14)
respectively.
(i) If rs is strictly decreasing on [c, d], the fitness function Gs attains its global maximum at y = c. Thus n̂s
and n̂s either vanish or are the Dirac mass concentrated at y = c. As a consequence we have n̂s = ñs = Sδ{y=c}
with S ≥ 0. Using the formula for n̂s, (4.5) and (4.6), we obtain (4.7)
(ii) The case n̂s = ñs = Sδ{y=c} with S > 0. Identity (4.8) follows from (4.6).
In the case αΣh = βΣs = 0, an entropy functional has been found by Jabin and Raoul [14] and used to prove
the convergence of the solution to the unique ESD. In the general form of the system (1.1), we do not expect
to find an entropy functional due to the complexity of the terms αΣh, βΣs. However, we obtain an entropy
functional similar to that of Jabin and Raoul for the system (4.2) corresponding to particular choices of αΣh and
βΣs. We obtain below a partial information about the dynamics of the solution of (4.2) as t→∞: the entropy
functional decreases monotonically on orbits. The question of the convergence of the solution to the unique ESD
remains open but this functional could be an essential ingredient to solve this issue.
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Proposition 4.6 (Entropy functional). Let (n̂h, n̂s) be an (non-negative) ESD of problem (4.2). Set
E(t) := β
∫
nh − β
∫
n̂h ln(nh) +
∫
ns −
∫
n̂s ln(ns).
Then E is an entropy functional for (4.2), i.e.,
d
dt
E(t) ≤ 0 provide that β is a positive constant satisfying
(β(1− b) + 1)2 ≤ 4β.
Proof. Set
E1 :=
∫
nh −
∫
n̂h ln(nh).
We have
d
dt
E1(t) =
∫
(nh)t(nh − n̂h)
nh
=
∫ [
rh(x)− ρh − ρs + (b− x)
∫
ns
]
(nh − n̂h)
=
∫ [
(rh(x)− ρh − ρs + (b− x)
∫
ns)− (rh(x)− ρ̂h − ρ̂s + (b− x)
∫
n̂s)
]
(nh − n̂h)
+
∫ [
rh(x)− ρ̂h − ρ̂s + (b− x)
∫
n̂s)
]
(nh − n̂h)
= −(ρh − ρ̂h)2 − (ρh − ρ̂h)(ρs − ρ̂s) +
∫
(b− x)(nh − n̂h)
∫
(ns − n̂s)
+
∫ [
rh(x)− ρ̂h − ρ̂s + (b− x)
∫
n̂s)
]
nh
≤ −(ρh − ρ̂h)2 − (ρh − ρ̂h)(ρs − ρ̂s) +
∫
(b− x)(nh − n̂h)
∫
(ns − n̂s).
In the above inequality, we have used the definition of ESDs and the non-negativity of nh (cf. Proposition 2.2).
Similarly, for E2 :=
∫
ns −
∫
n̂s ln(ns), we have
d
dt
E2(t) ≤ −(ρs − ρ̂s)2 − (ρh − ρ̂h)(ρs − ρ̂s) + β
∫
x(nh − n̂h)
∫
(ns − n̂s).
Therefore, as E = βE1 + E2, we have
dE
dt
≤ −β(ρh − ρ̂h)2 − [β(1− b) + 1](ρh − ρ̂h)(ρs − ρ̂s)− (ρs − ρ̂s)2 ≤ 0,
where the last inequality follows from the negativity of the discriminant of this polynomial:
(β(1− b) + 1)2 − 4β ≤ 0.
5 Dynamics of the fittest traits: an asymptotic point of view
We are interested in the dynamics of HSCs and stromal cells with initial data close to a monomorphic state and,
in particular, in tracking the movements of concentration point towards an ESD. We follows the analysis in [16]
and perform the time change variable τ = tε to accelerate time and observe the dynamics. The parameter ε is
also used to measure how close is the distribution from the Dirac distribution.
The change of variable t 7→ τ converts the system (3.1) to
∂τn
ε
h(τ, x) =
1
ε
[
rh(x)− ρεh(τ)− ρεs(τ) + α(x)Σs(τ)
]
nεh, x ∈ (a, b), τ > 0,
∂τn
ε
s(τ, y) =
1
ε
[
rs(y)− ρεh(τ)− ρεs(τ) + β(y)Σh(τ)
]
nεs, y ∈ (c, d), τ > 0.
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This system is completed with the initial data
nεh(0, x) = n
ε
h0(x) > 0, n
ε
s(0, y) = n
ε
s0(y) > 0.
Rather than working on nεh, n
ε
s directly, we define as usual [10, 16, 5] the functions u
ε, vε given by
uε(τ, x) = ε ln(nεh(τ, x)), u
ε
0(x) = ε ln(n
ε
h0(x)),
vε(τ, y) = ε ln(nεs(τ, y)), v
ε
0(y) = ε ln(n
ε
s0(y)).
The functions uε, vε satisfy
∂τu
ε(τ, x) = rh(x)− ρεh(τ)− ρεs(τ) + α(x)
∫
ynεs(τ, y), x ∈ (a, b), τ > 0,
∂τv
ε(τ, y) = rs(y)− ρεh(τ)− ρεs(τ) + β(y)
∫
xnεh(τ, x), y ∈ (c, d), τ > 0.
(5.1)
Our purpose is to study the behaviour of uε, vε as ε→ 0 (at least with subsequences). In order to guarantee
the existence of a global solution, suppose that (2.3) is fulfilled. Thus, under the assumption that ρεh0 + ρ
ε
s0
is uniformly bounded, Proposition 2.2 yields that there exists (n̂h, n̂s) such that as ε → 0 (after extracting
subsequences),
nεh
∗
⇀ n̂h in L
∞(0,∞;M([a, b])), (5.2)
nεs
∗
⇀ n̂s in L
∞(0,∞;M([c, d])). (5.3)
Theorem 5.1. Assume that rh, α ∈ C1([a, b]), rs, β ∈ C1([c, d]) and that
ρεh0 + ρ
ε
s0 + ‖uε0‖C1([a,b]) + ‖vε0‖C1([c,d]) ≤ K0. (5.4)
Then
(i) The function uε (resp. vε) is uniformly Lipschitz continuous on [0, T ] × [a, b] (resp. [0, T ] × [c, d]) for all
T > 0.
(ii) As ε→ 0 (after extractions of subsequences), the functions uε and vε converge locally uniformly to Lipschitz
continuous functions u and v. Moreover, u, v satisfy
u(τ, x) = u0(x) + rh(x)τ −
∫ τ
0
∫
n̂h −
∫ τ
0
∫
n̂s + α(x)
∫ τ
0
∫
yn̂s,
v(τ, y) = v0(y) + rs(y)τ −
∫ τ
0
∫
n̂h −
∫ τ
0
∫
n̂s + β(y)
∫ τ
0
∫
xn̂h,
maxτ,x u(τ, x) ≤ 0, maxτ,y v(τ, y) ≤ 0 for all τ ≥ 0.
(5.5)
Furthermore we have for a.e. τ ,
supp n̂h(τ, ·) ⊂ {u(τ, ·) = 0}, supp n̂s(τ, ·) ⊂ {v(τ, ·) = 0}.
Proof. (i) First note that by Proposition 2.2, there is a constant K1 > 0 such that
‖nεh‖L∞(0,∞;L1(a,b)) + ‖nεs‖L∞(0,∞;L1(c,d)) ≤ K1. (5.6)
Differentiating the equation for uε with respect to x yields
∂τu
ε
x(τ, x) = r
′
h(x) + α
′(x)
∫
ynεs(τ, y)dy. (5.7)
Thus, using (5.6), we obtain |∂τuεx(τ, x)| ≤ |r′h|+ |α′|dK1 so that
|uεx(τ, x)| ≤ K0 + (|r′h|+ |α′|dK1)τ.
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On the other hand, in view of (5.1), we have
|∂τuε(τ, x)| ≤ r̄h + 2K1 + αK1d.
Hence uε is uniformly Lipschitz continuous on [0, T ]× [a, b]. Similarly, the same property holds for vε.
(ii) Using the point (i) and the Arzelà–Ascoli Theorem, we may extract subsequences (uε, vε) which converge
as indicated in the statement. The equations for u and v are obtained by passing to the limit in (5.1). Moreover,
u, v cannot take positive values. Otherwise (ρεh, ρ
ε
s) blows up in the limit as ε vanishes and this is in contradiction
with (5.6).
5.1 Monomorphic states
We provide sufficient conditions so that (n̂h, n̂s) defined in (5.2), (5.3) is a monomorphic state.
Theorem 5.2. Let all hypotheses as in Theorem 5.1 hold. Suppose furthermore that{
uε0xx ≤ −K∗, vε0yy ≤ −K∗,
r′′h(x) ≤ 0, α′′(x) ≤ 0, r′′s (y) ≤ 0, β′′(y) ≤ 0.
(5.8)
Then, in the distributional sense
uxx ≤ −K∗, vyy ≤ −K∗.
Thus for all τ , the functions u(τ, ·), v(τ, ·) are concave so that they have a unique maximum point. As a conse-
quence, n̂h, n̂s have the form
n̂h(τ, x) = ρ̂h(τ)δ{x=x̂(τ)}, n̂s(τ, y) = ρ̂s(τ)δ{y=ŷ(τ)}.
Moreover,
If ρ̂h(τ) > 0, then max
x
u(τ, x) = u(τ, x̂(τ)) = 0,
If ρ̂s(τ) > 0, then max
y
v(τ, y) = v(τ, ŷ(τ)) = 0.
Proof. Differentiating twice the equation of uε, we obtain
∂τu
ε
xx(τ, x) = r
′′
h(x) + α
′′(x)
∫
ynεs(τ, y) ≤ 0.
Thus uεxx(τ, x) ≤ uεxx(τ = 0, x) ≤ −K∗. Therefore uxx ≤ −K∗. Similarly, vyy ≤ −K∗. Hence the theorem
follows.
5.2 Equations for concentration points
In this section we derive the equations for the concentration point x̂(τ), ŷ(τ). Our equations are valid until the
time T ∗ where ρ̂h(τ) > 0, ρ̂s(τ) > 0 and that x̂(τ), ŷ(τ) do not touch the boundary and that ˙̂x, ˙̂y are smooth
enough (see Remark 5.3 below for the regularity of x̂, ŷ). For all τ ∈ (0, T ∗) we have x̂(τ) ∈ (a, b) is the maximum
point of u(τ, ·) on [a, b]. It follows that ux(τ, x̂(τ)) = 0 so that
uxτ (τ, x̂(τ)) + uxx(τ, x̂(τ)) ˙̂x = 0 with ˙̂x := dx̂/dτ.
This implies
˙̂x(τ) = − 1
uxx(τ, x̂(τ))
[
r′h(x̂(τ)) + α
′(x̂(τ))
∫
yn̂s
]
= − 1
uxx(τ, x̂(τ))
[
r′h(x̂(τ)) + α
′(x̂(τ))ŷ(τ)ρ̂s(τ)
]
. (5.9)
Similarly, we have
˙̂y(τ) = − 1
vyy(τ, ŷ(τ))
[
r′s(ŷ(τ)) + β
′(ŷ(τ))x̂(τ)ρ̂h(τ)
]
. (5.10)
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The equations (5.9) and (5.10) describe the dynamics of x̂(τ), ŷ(τ). We also can obtain a more explicit form of
(5.9) and (5.10) by representing ρ̂h, ρ̂s in terms of x̂, ŷ. To that purpose, we first notice that u(τ, x̂(τ)) = 0 for
τ ∈ [0, T ∗) so that
0 =
du(τ, x̂(τ))
dτ
= uτ (τ, x̂(τ)) = rh(x̂(τ))− ρ̂h(τ)− ρ̂s(τ) + α(x̂(τ))ŷ(τ)ρ̂s(τ).
Similarly,
rs(ŷ(τ))− ρ̂h(τ)− ρ̂s(τ) + β(ŷ(τ)x̂(τ)ρ̂h(τ) = 0.
Therefore, under the assumption that 1− (1− α(x̂(τ))ŷ(τ))(1− β(ŷ(τ))x̂(τ)) 6= 0, we have
ρ̂h(τ) =
rh(x̂(τ))− rs(ŷ(τ))(1− α(x̂(τ))ŷ(τ))
1− (1− α(x̂(τ))ŷ(τ))(1− β(ŷ(τ))x̂(τ))
,
ρ̂s(τ) =
rs(ŷ(τ))− rh(x̂(τ))(1− β(ŷ(τ))x̂(τ))
1− (1− α(x̂(τ))ŷ(τ))(1− β(ŷ(τ))x̂(τ))
.
Substituting these expressions of ρ̂h(τ), ρ̂s(τ) in (5.9) and (5.10) we obtain
Canonical equations 
˙̂x = − 1
uxx(τ, x̂)
[
r′h(x̂) + α
′(x̂)ŷ
rs(ŷ)− rh(x̂)(1− β(ŷ)x̂)
1− (1− α(x̂)ŷ)(1− β(ŷ)x̂)
]
,
˙̂y = − 1
vyy(τ, ŷ)
[
r′s(ŷ) + β
′(ŷ)x̂
rh(x̂)− rs(ŷ)(1− α(x̂)ŷ)
1− (1− α(x̂)ŷ)(1− β(ŷ)x̂)
]
.
(5.11)
Remark 5.3. In view of the two first equations in (5.5), if u0, v0, rh, α, rs, β are smooth enough (e.g., C
2 functions),
then uxx is continuous. Thus the right-hand-sides of (5.11) are continuous as functions of x̂, ŷ, τ . Therefore, the
standard ordinary differential equation theory implies that the solution of (5.11) (x̂, ŷ) is a C1 function of time.
We refer to [21], for a results about the regularity of u, v in the case of Hamilton–Jacobi equations.
6 Numerical illustrations
Let us illustrate numerically the convergence of the solution of (3.1) towards an ESD as well as the movement
of concentration points. We employ the two distinct sets (a, b) := (1, 2) and (c, d) := (3, 4) to insist on that fact
that the two phenotypes of HSCs and of stromal cells are not the same. The space and time steps are given by
δx = δy = 0.005, δt = 0.01.
Define for 0 ≤ k ≤ 200 and p = 0, 1, 2, ...,
xk := 1 + kδx, yk := 3 + kδy, tp := pδt, (nh)
p
k := nh(tp, xk), (ns)
p
k := nh(tp, yk).
Our numerical simulations are performed in MATLAB and based on the implicit-explicit scheme below:
(nh)
p+1
k − (nh)
p
k
δt
= max
(
0, Rh(xk, (ρh)
p, (ρs)
p, (Σs)
p
)
(nh)
p
k
−max
(
0,−Rh(xk, (ρh)p, (ρs)p, (Σs)p
)
(nh)
p+1
k ,
(ns)
p+1
k − (ns)
p
k
δt
= max
(
0, Rs(xk, (ρh)
p, (ρs)
p, (Σs)
p
)
(ns)
p
k
−max
(
0,−Rs(yk, (ρh)p, (ρs)p, (Σh)p
)
(ns)
p+1
k ,
Rh(xk, (ρh)
p, (ρs)
p, (Σs)
p) := rh(xk)− (ρh)p − (ρs)p + α(xk)(Σs)p,
Rs(yk, (ρh)
p, (ρs)
p, (Σs)
p) := rs(yk)− (ρh)p − (ρs)p + β(yk)(Σh)p.
(6.1)
Here (ρh)
p, (ρs)
p, (Σh)
p, (Σs)
p are the approximation of ρh, ρs,Σh,Σs at the time p. We use the initial conditions
nh0 = exp(−(x− 1.5)2/0.01), ns0 = exp(−(y − 3.4).2/0.01)
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for Figures 3, 4, 5 and 6. For the last figures, we choose
nh0 = exp(−(x− 1.45)2/0.002), ns0 = exp(−(y − 3.58).2/0.002).
The parameters are chosen as in the table below.
Table 1: Settings in the numerical simulations.
Parameters Figures 3 and 4 Figures 5 and 6 Figures 7 and 8
(monomorphic situation) (monomorphic situation) (dimorphic situation)
healthy case leukemic case co-existence case
rh 0.1(x− 1) x− 1 0.75(x− 1)2
α 0.1(2− x) 0.4(2− x) 0.625(2− x)
rs 0.1 0.6(4.5− y) 0.5 + 0.25(3− y)
β 0.2(y − 3) + 1 0.1 0.5
Remark 6.1. The parameters in the three cases satisfy the assumptions of Theorem 4.2 (iii), (ii) and Proposi-
tion 4.3 (iii), respectively. Also they are chosen small enough such that the condition (2.3) for the global existence
of the solution holds. In the first case (Figures 3 and 4), we use the homogeneous proliferation rate and the in-
homogeneous sensitivity of stromal cells. Conversely, in the last two cases, the parameters correspond to the
inhomogeous proliferation rate and the homogeneous sensitivity of stromal cells. Note also that in the monomor-
phic situatations, the corresponding fitness functions are monotone while in the dimorphic situation, the fitness
function (for HSCs) is strictly convex.
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Figure 3: Behaviour of HSCs (first row) and stromal cells (second row) in time. Stromal cells with best support
capacity are selected and healthy HSCs persist (no LSCs).
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Figure 4: Evolution of the dominant trait (horizontal axis for the distribution of traits) with time (vertical axis).
Left: phenotype x of HSCs. Right: Phenotype y of stromal cells. Monomorphic states for HSCs and stromal
cells.
Figure 3 and Figure 4 display the behavior of nh and ns in the time scale t := 10
−2t. In Figure 3, the
population densities for HSCs and their support cells nh, ns are monomorphic and behave as Dirac masses. The
concentration point of nh moves towards x = 1 and the one of ns moves towards the point y = 4. In this
situation, the phenotype (x, y) = (1, 4) is selected. This represents a good scenario: healthy HSCs and stromal
cells with the best support capacity are selected. The evolution of the corresponding dominant phenotypes are
given in Figure 4. Figures 5 and 6 below show another monomorphic situation where stromal cells with lowest
support capacity are selected. Healthy HSCs cannot survive and cancer cells are selected.
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Figure 5: Behaviour of HSCs (first row) and stromal cells (second row) in time. Stromal cells with lowest support
capacity are selected. Healthy HSCs go extinct and LSCs persist.
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Figure 6: Left: phenotype x of HSCs. Right: Phenotype y of stromal cells (phenotype space in abscissae, time
in ordinates). The support is not sufficient and healthy HSCs cannot persist; only LSCs survive. One can notice
an apparent fracture between the two populations around the middle of the phenotype space.
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Figure 7: Behaviour of HSCs (first row) and stromal cells (second row) in time. Stromal cells with lowest support
capacity are selected. HSCs and LSCs coexist (carefully note the concentration around both x = 1 and x = 2 in
the first row).
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Figure 8: Left: The dominant phenotypes for HSCs move towards the left and right. The phenotypes x = 1 and
x = 2 are selected, i.e., both healthy and malignant HSCs persist. Right: Evolution of dominant phenotypes for
stromal cells. Stromal cells with the lowest capacity of the support are selected.
Figures 7 and 8 represent the dimorphic situation for HSCs in the time scale t := 10−2t. This situation
corresponds to Proposition 4.3 (iii). Starting from an initial distribution with one peak at x = 1.45, a branching
process appears. There are two dominant phenotypes of HSCs. The first one moves to the left (only healthy cells
selected about the time until t = 10) and the second one move towards x = 2 (and selected in a little bit later).
In other words, cancerous cells invade the population of HSCs, however without occupying it in totality: healthy
HSCs and cancerous cells (LSCs) coexist.
7 Conclusion and perspectives
In this paper, we have introduced a mathematical model for the interaction between hematopoietic stem cells
and their support cells. Leukemic stem cells are also taken into account in the model and the phenotype
x, characterising the population heterogeneity in a way relevant to the question at stake, represents for both
the intrinsic proliferation rate of HSCs and the malignancy potential of cancer cells (i.e., as mentioned in the
introduction, a proposed pathological combination of both plasticity and fecundity, likely related to how many
mutations are involved in cancer cells). Note also that the monotonicity assumption on rh means that we assumed
that the malignant cells proliferate more than healthy HSCs.
We performed a study concerning the adaptive dynamics of HSCs and support cells, in particular, investigating
Dirac masses (or sums of Dirac masses) that arose in the solutions of particular cases of the system. Linear
stability results for single Dirac mass steady states, suggesting that another phenotype will invade the stationary
environment corresponding to the steady state if the corresponding fitness function computed at that phenotype
is positive. We also provided sufficient conditions to ensure that ESDs are dimorphic or monomorphic. These
conditions are related to the convexity, concavity, monotonicity assumptions of the function parameters. In many
cases, we could show the existence and uniqueness of ESDs as well as compute explicitly all ESDs in the case of
non-uniqueness.
Applying an asymptotic approach, we showed that without extinction, the population density of HSCs and
of their support cells behave as Dirac masses:
nεh(τ, x) ≈ ρ̂h(τ)δ{x=x̂(τ)} with ρ̂h(τ) > 0⇔ max
x
u(τ, x) = 0 = u(τ, x̂(τ))
nεs(τ, y) ≈ ρ̂s(τ)δ{y=ŷ(τ)} with ρ̂s(τ) > 0⇔ max
y
v(τ, x) = 0 = v(τ, ŷ(τ)).
Here the points of concentration x̂(τ), ŷ(τ) represent well adapted phenotypes at the time τ . Also these points
are maximum points of the phase functions u(·, τ) and v(·, τ). The system (5.11) gives us the dynamics of
x̂(τ), ŷ(τ), in other words, the adaptive process for HSCs and its support cells during their evolution. Our
numerical illustrations provide the case of the existence of HSCs, or LCSs (only). Also, we illustrate the case of
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invasion of LCSs as well as the coexistence of HSCs and LSCs. This latter situation does not seem to be usually
seen in the clinic of acute leukemias, which may be due to the fact that in reality, the competition for space and
nutrients turns to the advantage of leukemic cells (The biological fact is that stromal cells change to adapt to
healthy cells or malignant cells. Thus LSCs and HSCs have different hematopoietic niches so that the competitive
strength of HSCs and LSCs for space and nutrients will be different). In our model, the advantage of leukemic
cells in competition could be represented by a diversified non local logistic term in the equation for HSCs such
as −k1
∫
(b−x)nh(t, x)dx− k2
∫
(x−a)nh(t, x)dx, with k2 > k1, instead of the neutral term −ρh, thus attributing
more importance in the competition to cells close to the malignant phenotype x = b. Or else, could it be that
actual biological coexistence between HSCs and LSCs could come from the fact that leukemic cells may have
been reduced to a state of dormancy? Note that this perspective of dormancy has recently been investigated in
a rather different modelling setting (no adaptive dynamics, no interaction with stromal cells) in [11].
Our analytic results, except in Section 4.2, hold for more general choices of the weight functions ψh, ψs.
However, we present our results here mainly for the case ψh = x, ψs = y to clarify the ideas and avoid complex
computations. The mathematical question related to the convergence of the solution of (1.1) to its limit (which
is an ESD) remains open. The BV-method (see, for example, [23, 17]) seems not amenable be applied due to the
complexity of function parameters. However, we could find an entropy functional for a simplified system (4.2).
This functional decreases to −∞, however it could be an essential ingredient to solve this issue.
The present model and its mathematical analysis represent to the best of our knowledge a first attempt to
study the interactions between HSCs and their supporting stromal cells in the framework of adaptive dynamics.
One could certainly complicate it to introduce multidimensional phenotypes related to refined cell functionalities
such as fecundity, viability, plasticity, in the two cell populations, but even simple as it is, it relies on many
unknown functions that should first be experimentally evaluated to go further in this modelling work, which we
actually plan to do in the future.
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